Search Results - "Rey Cardenas, M."

Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future by Rey-Cárdenas, M., Guerrero-Ramos, F., Gómez de Liaño Lista, A., Carretero-González, A., Bote, H., Herrera-Juárez, M., Carril-Ajuria, L., Martín-Soberón, M., Sepulveda, J.M., Billalabeitia, E.G., Castellano, D., de Velasco, G.

“…•The localized muscle-invasive bladder cancer relapse rate is remarkably high.•Immunotherapy has transformed the treatment landscape of bladder cancer.•The…”
Get full text

Targeting HIF-2α and anemia: A therapeutic breakthrough for clear-cell renal cell carcinoma by Rioja, Patricia, Rey-Cardenas, M., De Velasco, Guillermo

“…•Recent research in RCC pathogenesis has emphasized its heterogeneity, with a focus on the VHL gene's critical role in oxygen sensing and the subsequent…”
Get full text

1768P Clinical outcomes with platinum-based chemotherapy after progression on frontline immunotherapy in metastatic urothelial cancer (mUC) by Szabados, B.E., Stockem, C.F., Castellano Gauna, D.E., Gomez de Liano Lista, A., Rey Cardenas, M., Perez Valderrama, B., Powles, T.B., van der Heijden, M.S.

Get full text

49P Analysis of HER2-low carcinomas and PAM50 signature in an early-stage breast cancer cohort by Sanchez Bayona, R., Tolosa, P., Alba Bianchi, M., Madariaga Urrutia, A., Teran, S., Rey Cardenas, M., Lema Roso, L., Ruano, Y., Manso, L., Ciruelos, E.M.

Get full text

P172 Analysis of circulating tumor DNA in treatment-naive patients with metastatic renal cell carcinoma by Rey Cárdenas, M., Gavira, J., Bayle, A., Naoun, N., Courtier, B., Alves Costa Silva, C., Crouzet, L., Estrade, F., Verret, B., Italiano, A., Escudier, B., Flippot, R., Albiges, L.

Get full text